Related Experiment Video For Activated partial thromboplastin time
Updated: May 10, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Co-relation of coagulation profile with glycemic index in patients with type 2 diabetes
Sushil Kumar1, Soma Dey1, Abhilasha Bankul2
1Department of Biochemistry, AIIMS, Patna, Bihar, India.
Background:
Diabetes mellitus (DM) has emerged as a significant global concern that accounts for nearly 90% of type 2 DM cases worldwide and characterized by insulin resistance. Hyperglycemia in diabetes leads to increased fibrinogen levels and activates the coagulation cascade, thereby triggering atherothrombotic events.
Aim And Objective:
The study was designed to evaluate the coagulation profile (activated partial thromboplastin time, prothrombin time, and INR) in type 2 diabetes and to analyze the correlation between glycated hemoglobin (A1C) and coagulation profile among the OPD patients coming to AIIMS Patna.
Methods:
A total of 234 patients were included in the study who were divided into 3 categories based on their glycemic status. 85 were non-diabetic, 65 were pre-diabetic, and 84 were diabetic. The demographic profile and clinical details were recorded. Fasting blood glucose, glycated hemoglobin, coagulation parameters such as prothrombin time, INR, and activated partial thromboplastin time along with other biochemical parameters were investigated.
Results:
There was a statistically significant association found between the coagulation profile and the two groups (Diabetics and Non-diabetics). The present study also found significant correlations between age and the diabetic group as compared to the non-diabetic group. A strong statistical significance was found between the gender and coagulation profile PT/INR. A statistically significant difference was found in the pre-diabetic and diabetic groups for coagulation parameters such as the activated partial thromboplastin time and prothrombin time (APTT and PT).
Conclusion:
Clinical tests for prothrombin time, INR, and activated partial thromboplastin time are relatively inexpensive and readily available. The present study shows that a significant association was found between prothrombin time and activated partial thromboplastin time with the glycemic status among the diabetic as compared to non-diabetic or pre-diabetics. These findings can be used as important hemostatic markers in diabetic patients, especially in those at high risk for thrombotic complications.
More Related Videos
07:09Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...